Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steen Stender

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
International Journal of Cardiology|June 4, 2019
Polygenic predisposition to breast cancer and the risk of coronary artery diseaseMaria D'Souza, Morten Schou, Regitze Skals, et al.
Plos One|December 20, 2018
Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiographyMaria Lukács Krogager, Regitze Kuhr Skals, Emil Vincent R Appel, et al.
Plos One|October 26, 2023
Correction: Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiographyMaria Lukács Krogager, Regitze Kuhr Skals, Emil Vincent R Appel, et al.
Plos One|February 7, 2019
Association of genetic variants previously implicated in coronary artery disease with age at onset of coronary artery disease requiring revascularizationsCharlotte Andersson, Maria Lukács Krogager, Regitze Kuhr Skals, et al.
The Journal of Allergy and Clinical Immunology|August 28, 2012
Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrationsJacob P Thyssen, Betina Thuesen, Cornelia Huth, et al.
The New England Journal of Medicine|March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events, Rury R Holman, Steven M Haffner, et al.
The New England Journal of Medicine|March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events, John J McMurray, Rury R Holman, et al.
Nature Communications|January 11, 2020
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failureSonia Shah, Albert Henry, Carolina Roselli, et al.
ESC Heart Failure|September 4, 2021
The genomics of heart failure: design and rationale of the HERMES consortiumR Thomas Lumbers, Sonia Shah, Honghuang Lin, et al.
Circulation. Genomic and Precision Medicine|March 22, 2019
Subsequent Event Risk in Individuals With Established Coronary Heart DiseaseRiyaz S Patel, Vinicius Tragante, Amand F Schmidt, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
International Journal of Cardiology|June 4, 2019
Polygenic predisposition to breast cancer and the risk of coronary artery diseaseMaria D'Souza, Morten Schou, Regitze Skals, et al.
Plos One|December 20, 2018
Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiographyMaria Lukács Krogager, Regitze Kuhr Skals, Emil Vincent R Appel, et al.
Plos One|October 26, 2023
Correction: Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiographyMaria Lukács Krogager, Regitze Kuhr Skals, Emil Vincent R Appel, et al.
Plos One|February 7, 2019
Association of genetic variants previously implicated in coronary artery disease with age at onset of coronary artery disease requiring revascularizationsCharlotte Andersson, Maria Lukács Krogager, Regitze Kuhr Skals, et al.
The Journal of Allergy and Clinical Immunology|August 28, 2012
Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrationsJacob P Thyssen, Betina Thuesen, Cornelia Huth, et al.
The New England Journal of Medicine|March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events, Rury R Holman, Steven M Haffner, et al.
The New England Journal of Medicine|March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events, John J McMurray, Rury R Holman, et al.
Nature Communications|January 11, 2020
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failureSonia Shah, Albert Henry, Carolina Roselli, et al.
ESC Heart Failure|September 4, 2021
The genomics of heart failure: design and rationale of the HERMES consortiumR Thomas Lumbers, Sonia Shah, Honghuang Lin, et al.
Circulation. Genomic and Precision Medicine|March 22, 2019
Subsequent Event Risk in Individuals With Established Coronary Heart DiseaseRiyaz S Patel, Vinicius Tragante, Amand F Schmidt, et al.
Pageof 11